潘

潘宇

Cadre supérieur

康缘药业

Insider activity · 24 months1 buy0 salesCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 1 buy · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€3,644

▼ Sales (0 ops.)

—

Latest filing published 21 Nov 2025 for 康缘药业, €3,644.

Filing timeline

BuySale

潘宇

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

康缘药业 1 purchase · last 21 Nov 2025

Since each purchase

康缘药业
Filed 21 Nov 2025 · 352 days ago · €3,644
-5.7%
Entry CN¥15.33 · Close at T+90 CN¥14.46

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

潘宇: trading record in brief

Only one filing by 潘宇 is known so far (21 November 2025): an open-market purchase, €3,644, in 康缘药业. That is too little to draw conclusions. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to 潘宇

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

康缘药业 (CN)

Declarations1 total

▲
潘宇
高级管理人员Executives21 Nov 2025康缘药业
29,880 CNY31SSE
2,000 shares100.0% of flowA股XSHGSSE:173000009822885630
Canonical exit: 19 Feb 2026 (T+90)

1 of 1 declaration

潘宇